Breaking News Instant updates and real-time market news.

ARNA

Arena Pharmaceuticals

$39.14

2.11 (5.70%)

07:17
04/19/18
04/19
07:17
04/19/18
07:17

Arena's APD371 'another underappreciated asset,' says Cantor Fitzgerald

Cantor Fitzgerald analyst William Tanner views Arena Pharmaceuticals' APD371 in Crohn's abdominal pain as "another underappreciated asset." Release of data from clinical testing is expected in Q2, but is unlikely to have a significant impact on the stock given its early nature, Tanner tells investors in a research note. He believes, however, that APD371's underlying pharmacology could positively position the drug candidate favorably versus other cannabinoid receptor modulators. The analyst raised his price target for the shares to $65 from $64 and keeps an Overweight rating on Arena Pharmaceuticals.

  • 20

    Apr

  • 21

    May

ARNA Arena Pharmaceuticals
$39.14

2.11 (5.70%)

03/20/18
NEED
03/20/18
UPGRADE
Target $60
NEED
Buy
Arena Pharmaceuticals upgraded to Buy at Needham on phase 2 UC data
As reported earlier, Needham analyst Alan Carr upgraded Arena Pharmaceuticals to Buy from Hold with a price target of $60. Carr cites the company's "impressive results" from its Phase 2 Ulcerative Colitis study unveiled yesterday, noting that the the safety and tolerability data components are also "encouraging". The analyst adds that the favorable outcome warrants an update to his pricing model, particularly in light of "substantial" unmet need in the Inflammation space where there are few S1P modulators currently in development.
03/20/18
JMPS
03/20/18
NO CHANGE
Target $79
JMPS
Outperform
Arena Pharmaceuticals price target raised to $79 from $63 at JMP Securities
JMP Securities analyst Jason Butler said Arena Pharmaceuticals' top-line results for etrasimod in ulcerative colitis meet or beat his best-case expectations and he has increased his view of the probability of success for etrasimod in UC to 75% from 50% following the report of the data. Given the higher odds he places on the success of the drug in that indication, Butler raised his price target on Arena shares to $79 from $63 and keeps an Outperform rating on the stock.
03/20/18
03/20/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Universal Display (OLED) upgraded to Buy from Hold at Gabelli with analyst Hendi Susanto saying he views the negative market response to a Bloomberg report that Apple (AAPL) is designing and producing MicroLED display prototypes as an overreaction and a buying opportunity. 2. Oneok (OKE) upgraded to Buy from Hold at Jefferies with analyst Christopher Sighinolfi saying he is confident in Oneok's ability to hit target returns on $4.2B of its current projects following a recent meeting with management. 3. PPG (PPG) upgraded to Buy from Hold at Deutsche Bank with analyst David Begleiter saying he believes the company's capital deployment and "valuation discount" are attractive. 4. Roku (ROKU) upgraded to Perform from Underperform at Oppenheimer with analyst Jason Helfstein upgraded Roku (ROKU) to Perform citing valuation and the company's opportunity in virtual multichannel video programming distribution. 5. Arena Pharmaceuticals (ARNA) upgraded to Buy from Hold at Needham with analyst Alan Carr citing the company's "impressive results" from its Phase 2 Ulcerative Colitis study, noting that the the safety and tolerability data components are also "encouraging." This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/21/18
SBSH
03/21/18
NO CHANGE
Target $62
SBSH
Buy
Arena Pharmaceuticals price target raised to $62 from $55 at Citi
Citi analyst Joel Beatty raised his price target for Arena Pharmaceuticals to $62 after the company announced positive Phase 2 topline results for etrasimod in ulcerative colitis. The analyst increased his market penetration projections for etrasimod and maintained a 60% probability of success for the drug. He keeps a Buy rating on Arena Pharmaceuticals.

TODAY'S FREE FLY STORIES

APRN

Blue Apron

$3.14

0.17 (5.72%)

, KR

Kroger

$24.58

0.02 (0.08%)

15:40
05/24/18
05/24
15:40
05/24/18
15:40
Hot Stocks
Blue Apron jumps after Kroger buys meal-kit peer Home Chef »

Shares of meal-kit…

APRN

Blue Apron

$3.14

0.17 (5.72%)

KR

Kroger

$24.58

0.02 (0.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PBR

Petrobras

$12.87

-2.235 (-14.80%)

15:40
05/24/18
05/24
15:40
05/24/18
15:40
Options
Active trading in Petrobras options as shares face heavy selling »

Active trading in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JBLU

JetBlue

$19.02

0.34 (1.82%)

15:36
05/24/18
05/24
15:36
05/24/18
15:36
Hot Stocks
JetBlue announces Fort Lauderdale as its home for JetBlue Travel Products »

JetBlue announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPLK

Splunk

$116.68

0.13 (0.11%)

15:34
05/24/18
05/24
15:34
05/24/18
15:34
Options
Splunk options imply 8.1% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 10

    Jul

VFC

VF Corp.

$82.17

0.89 (1.10%)

15:30
05/24/18
05/24
15:30
05/24/18
15:30
Options
Defensive short-term play opened in VF Corp »

Defensive short-term play…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PYPL

PayPal

$82.78

1.71 (2.11%)

15:29
05/24/18
05/24
15:29
05/24/18
15:29
Hot Stocks
PayPal sees FXN revenue growth of 17%-18% CAGR over medium-term »

Sees non-GAAP EPS growth…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 30

    May

  • 12

    Jun

PYPL

PayPal

$82.56

1.49 (1.84%)

15:26
05/24/18
05/24
15:26
05/24/18
15:26
Hot Stocks
PayPal targeting $1B-$3B per year for M&A »

PayPal CFO John Rainey is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 30

    May

  • 12

    Jun

JNJ

Johnson & Johnson

$122.16

-1.3 (-1.05%)

15:26
05/24/18
05/24
15:26
05/24/18
15:26
Hot Stocks
Jury delivers $25.75M verdict in Johnson & Johnson baby powder case »

A jury in California…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jun

15:25
05/24/18
05/24
15:25
05/24/18
15:25
General news
Treasury Closing Summary: »

Treasury Closing Summary:…

LXFT

Luxoft

$32.80

-10.55 (-24.34%)

15:23
05/24/18
05/24
15:23
05/24/18
15:23
Downgrade
Luxoft rating change  »

Luxoft downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

PYPL

PayPal

$82.25

1.18 (1.46%)

15:19
05/24/18
05/24
15:19
05/24/18
15:19
Hot Stocks
PayPal at session highs, up 2% to $82.63 as CFO presents at investor day »

PayPal CFO John Rainey is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 30

    May

  • 12

    Jun

GPS

Gap

$32.87

0.9 (2.82%)

15:19
05/24/18
05/24
15:19
05/24/18
15:19
Options
Gap options imply 9.6% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

TMUS

T-Mobile

$57.03

0.01 (0.02%)

15:17
05/24/18
05/24
15:17
05/24/18
15:17
Periodicals
T-Mobile glitch let anyone access customer account data, ZDNet reports »

A glitch in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

15:17
05/24/18
05/24
15:17
05/24/18
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

15:16
05/24/18
05/24
15:16
05/24/18
15:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,605.50

3.73 (0.23%)

15:14
05/24/18
05/24
15:14
05/24/18
15:14
Periodicals
Family claims Amazon device recorded, shared private conversation, Kiro7 says »

A Portland family has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Jun

ADSK

Autodesk

$139.19

-0.11 (-0.08%)

15:04
05/24/18
05/24
15:04
05/24/18
15:04
Options
Autodesk options imply 8.1% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 14

    Jun

SJM

J.M. Smucker

$109.22

-0.98 (-0.89%)

15:00
05/24/18
05/24
15:00
05/24/18
15:00
Options
Notable spread in JM Smucker »

Notable spread in JM…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jun

  • 15

    Aug

DB

Deutsche Bank

$12.29

-0.605 (-4.69%)

14:58
05/24/18
05/24
14:58
05/24/18
14:58
Periodicals
Deutsche Bank shareholders vote down motion to remove Chairman, Reuters says »

About 91% of Deutsche…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TOT

Total

$61.03

-0.36 (-0.59%)

14:51
05/24/18
05/24
14:51
05/24/18
14:51
Hot Stocks
Total acquires 10% interest in Novatek's Arctic LNG 2 project »

Chairman of the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IGLD

Internet Gold

$3.38

0.37 (12.29%)

14:49
05/24/18
05/24
14:49
05/24/18
14:49
Technical Analysis
Technical Take: Internet Gold spikes after results »

The stock was last up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NTNX

Nutanix

$56.05

-0.19 (-0.34%)

14:49
05/24/18
05/24
14:49
05/24/18
14:49
Options
Nutanix options imply 13.3% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 07

    Jun

  • 10

    Jul

TAHO

Tahoe Resources

$5.11

-0.195 (-3.68%)

14:45
05/24/18
05/24
14:45
05/24/18
14:45
Options
Tahoe Resources call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NKE

Nike

$72.03

0.71 (1.00%)

, UA

Under Armour

$18.34

0.45 (2.52%)

14:29
05/24/18
05/24
14:29
05/24/18
14:29
Periodicals
Nike to take MLB on-field rights from Under Armour in 2020 season, SBD says »

MLB's on-field…

NKE

Nike

$72.03

0.71 (1.00%)

UA

Under Armour

$18.34

0.45 (2.52%)

UAA

Under Armour

$20.50

0.43 (2.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 26

    Jun

IGLD

Internet Gold

$3.22

0.21 (6.98%)

14:25
05/24/18
05/24
14:25
05/24/18
14:25
Earnings
Internet Gold jumps 20% to $3.65 after disclosing Q1 results 

Reference Link

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.